The rat urinaryprostacyclin as well as other

[1]  G. Hamilton,et al.  The Relationship Between Prostacyclin Activity and Pressure in the Portal Vein , 2007, Hepatology.

[2]  H. Prentice,et al.  Treatment of cyclophosphamide-induced cystitis with prostaglandin E2. , 1984, Annals of internal medicine.

[3]  A. Nasjletti,et al.  Effect of uninephrectomy on urinary prostaglandin E2, F2 alpha, and 6-ketoprostaglandin F1 alpha excretion in rats. , 1984, Clinical science.

[4]  D. Mikhailidis,et al.  Prostacyclin Production by the Urinary Bladder , 1984 .

[5]  D. Mikhailidis,et al.  Effect of ethanol on vascular prostacyclin (prostaglandin I2) synthesis, platelet aggregation, and platelet thromboxane release. , 1983, British medical journal.

[6]  R. Branch,et al.  SYSTEMIC PROSTAGLANDIN I2 SYNTHESIS IS NORMAL IN PATIENTS WITH BARTTER'S SYNDROME , 1983, The Lancet.

[7]  J. Nadler,et al.  CIGARETTE SMOKING INHIBITS PROSTACYCLIN FORMATION , 1983, The Lancet.

[8]  J. Nadler,et al.  Stimulation of renal prostaglandins by pressor hormones in man: comparison of prostaglandin E2 and prostacyclin (6 keto prostaglandin F1 alpha). , 1983, The Journal of clinical endocrinology and metabolism.

[9]  D. Mikhailidis,et al.  PROSTACYCLIN RELEASE IN VIVO , 1983, The Lancet.

[10]  R. Russell,et al.  Effect of aspirin on urinary excretion of 6-ketoprostaglandin F1 alpha. , 1983, Clinical science.

[11]  D. Mikhailidis,et al.  Simulating the Diabetic Environment Modifies In Vitro Prostacyclin Synthesis , 1983, Diabetes.

[12]  C. Dollery,et al.  RELEASE OF PROSTACYCLIN IN VIVO AND ITS ROLE IN MAN , 1983, The Lancet.

[13]  J. Sassard,et al.  A new technique for the measurement of urinary 6-keto-prostaglandin F1α: normal values in adults , 1982 .

[14]  M. Epstein,et al.  Augmentation of prostaglandin production by linoleic acid in man. , 1982, Clinical science.

[15]  D. Mikhailidis,et al.  Effect of Calcium and Potassium on in Vitro Vascular Prostacyclin Synthesis , 1982 .

[16]  G. Tytgat,et al.  Effect of 15(R)-15-methyl prostaglandin E2 (arbaprostil) on the healing of duodenal ulcer: a double-blind multicenter study. , 1982, Gastroenterology.

[17]  S. Nassar,et al.  Pharmacotherapeutics of prostaglandin E2 and 15 (S) 15-methyl prostaglandin F2 alpha in chronic schistosomal bladder ulcer: a clinico-endoscopic study. , 1982, Prostaglandins.

[18]  B. Jaffe,et al.  Prostaglandin E augments the effect of chemotherapy on B-16 melanoma in vivo. , 1982, The Journal of surgical research.

[19]  C. Patrono,et al.  Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. , 1982, The Journal of clinical investigation.

[20]  S. Narumiya,et al.  Prostaglandin D2, a potential antineoplastic agent. , 1982, Biochemical and biophysical research communications.

[21]  C. Dollery,et al.  Prostacyclin is not a circulating hormone in man. , 1982, Prostaglandins.

[22]  F. Carey,et al.  Prostacyclin and thromboxane A , 1982 .

[23]  M. Greaves,et al.  Prostacyclin and thromboxane A , 1982, British medical journal.

[24]  A. Toth,et al.  Bronchial hyperreactivity in response to inhalation of ultrasonically nebulised solutions of distilled water and saline , 1982, British medical journal.

[25]  J. Webster.  Prostacyclin and thromboxane in diabetes , 1981 .

[26]  E. Christ-Hazelhof,et al.  Prostacyclin is not a circulating hormone. , 1981, Prostaglandins.

[27]  J. Vane,et al.  Prostacyclin: homeostatic regulator or biological curiosity? , 1981, Clinical science.

[28]  J. Oates,et al.  Quantitative analysis of two dinor urinary metabolites of prostaglandin I2. , 1981, Analytical biochemistry.

[29]  M. Lifschitz,et al.  High urine flow rate increase prostaglandin E excretion in the conscious dog. , 1981, Prostaglandins.

[30]  J. Frölich,et al.  Relevance of urinary 6-keto-prostaglandin F1α determination , 1981 .

[31]  Y. Inada,et al.  Enhanced thromboxane A2 biosynthesis in the kidney of spontaneously hypertensive rats during development of hypertension. , 1981, European journal of pharmacology.

[32]  G. Hamilton,et al.  Portal vein prostacyclin activity in experimental portal hypertension in rats. , 1981, Clinical science.

[33]  C. Cerletti,et al.  PROSTACYCLIN OVERPRODUCTION IN BARTTER'S SYNDROME , 1979, The Lancet.

[34]  P. Needleman,et al.  Thromboxane A2 biosynthesis in the ureter obstructed isolated perfused kidney of the rabbit. , 1978, The Journal of pharmacology and experimental therapeutics.

[35]  E. Corey,et al.  Renal actions of prostacyclin , 1978, Nature.

[36]  R Goldsmith,et al.  The epidemiology of bladder cancer. A second look , 1977, Cancer.

[37]  D. Mikhailidis,et al.  The effect of tiaprofenic acid and indomethacin on vascular prostacyclin and platelet thromboxane A2 production. , 1985, Pharmatherapeutica.

[38]  D. Mikhailidis,et al.  Does human placenta produce prostacyclin? , 1985, Placenta.

[39]  Å. Wennmalm.  Interaction of nicotine and prostaglandins in the cardiovascular system. , 1982, Prostaglandins.

[40]  P. Weber,et al.  Analysis of 6-keto-prostaglandin F1α in human urine: Age-specific differences , 1982 .

[41]  C. Patrono,et al.  Evidence for a direct stimulatory effect of prostacyclin on renin release in man. , 1982, The Journal of clinical investigation.

[42]  A. Dembińska-kieć,et al.  Role of prostaglandins in the formation of aspirin-induced gastric ulcers , 1981 .

[43]  A. Dembińska-kieć,et al.  Gastric cytoprotection by prostaglandins, ranitidine, and probanthine in rats. Role of endogenous prostaglandins. , 1981, Scandinavian journal of gastroenterology.

[44]  T. K. Chaudhury,et al.  Prostaglandin cytoprotection of gastric mucosa. , 1978, Gastroenterology.